Is this your brand? Sign in to claim ownership.
Sign in to claim this brandBRUNO PHARMA INNOVATIONS, LLC
US
Last updated May 30, 2026
What BRUNO PHARMA INNOVATIONS, LLC makes
Bruno Pharma Innovations, LLC manufactures multiple clinical chemistry analyte monitoring systems for in vitro diagnostic use that are designed for home use. The company also produces glucose in vitro diagnostic kits for in vitro diagnostic testing that use electrometry as the measurement method.
The devices in the company's portfolio are classified as either Class I or Class II medical devices and are listed in the FDA's Unique Device Identification system. The company is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What type of devices does Bruno Pharma Innovations, LLC manufacture?
Bruno Pharma Innovations, LLC makes in vitro diagnostic devices, including multiple clinical chemistry analyte monitoring systems and glucose kits, because the company summary states this information.
Where is Bruno Pharma Innovations, LLC based?
The company is based in the US, as indicated in the country field of the device data.
Which registries list devices from Bruno Pharma Innovations, LLC?
Devices from Bruno Pharma Innovations, LLC are listed in the FDA's Unique Device Identification system, known as fda_udi, according to the listed in field.
How are devices from Bruno Pharma Innovations, LLC classified?
The devices are classified as either Class I or Class II medical devices, because the device classes field states this classification.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 080469071
Catalogue (3)
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.